Cancer

Mopec Expands Partnership with Lumea to Deliver Seamless Digital Pathology Integration and Consumables Access

MADISON HEIGHTS, Mich., Sept. 28, 2025 /PRNewswire/ -- Mopec, a leader in pathology and anatomy innovation, is proud to announce the…

3 months ago

The American Cancer Society and National Football League’s (NFL) Crucial Catch Initiative Works to Improve Cancer Screening Rates

By addressing access to screening in NFL markets, Crucial Catch improves cancer outcomes nationwide.   ATLANTA, Sept. 26, 2025 /PRNewswire/…

3 months ago

Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025

BOONE, N.C., Sept. 26, 2025 /PRNewswire/ -- Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify…

3 months ago

Strategic Collaboration Formed Between Leo Cancer Care and Sumitomo Heavy Industries for Upright Proton Therapy

MIDDLETON, Wis., Sept. 26, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in innovative cancer care solutions, and Sumitomo Heavy Industries,…

3 months ago

Factor Bioscience Files Complaint Against Cellectis and AstraZeneca Alleging Infringement of Foundational Gene-Editing Patents

Alleges infringement of three U.S. gene-editing patentsInfringed patents support multiple product pipelines, including Factor's allogeneic cancer cell therapy programsCites need…

3 months ago

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy…

3 months ago

Aesthetic Surgery Center Wins First Place in Three Categories in the 2025 Best of Naples Community’s Choice Awards

For the eighth year, the Aesthetic Surgery Center is honored by the Naples Community's Choice Awards, with recognition spanning surgical…

3 months ago

Exousia Pro Reports Positive Outcome in Legal Proceeding

Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia…

3 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology…

3 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company…

3 months ago